The pathway "Signaling by EGFR in Cancer" shows signaling by constitutively active EGFR cancer variants in the context of "Signaling by EGFR", allowing users to compare cancer events with the wild-type EGFR events. Red lines emphasize cancer related events and physical entities, while wild-type entities and events are shaded. Please refer to "Signaling by Ligand-Responsive EGFR Variants in Cancer", "Signaling by EGFRvIII in Cancer" and "Signaling by Overexpressed Wild-Type EGFR in Cancer" for detailed pathway summations

external resources

CBL , EGF , EGFR , GAB1 , GRB2 , HRAS , HSP90AA1 , KRAS , NRAS , PIK3CA , PIK3R1 , PLCG1 , RPS27A , SHC1 , SOS1 , UBA52 , UBB , UBC , CDC37 , MIR1181 ,